Diana Eccles

52.3k citations

183 papers · 9.0k · 4 hit papers · h-index 49

Impact in

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Genetics top 0.1%
- BRCA gene mutations in cancer
- Genomic variations and chromosomal abnormalities

Papers in

Genetics 111
- BRCA gene mutations in cancer 97
- Genomic variations and chromosomal abnormalities 14
Oncology 60
- Global Cancer Incidence and Screening 16
- Cancer-related Molecular Pathways 14

Co-authors: D. Gareth Evans (57 shared papers)Douglas F. Easton (11 shared papers)Nazneen Rahman (10 shared papers)Sheila Seal (8 shared papers)Michael R. Stratton (8 shared papers)Rita Barfoot (6 shared papers)Anthony Renwick (6 shared papers)Hiran Jayatilake (5 shared papers)
Journals: Journal of Medical Genetics (15 papers)British Journal of Cancer (14 papers)Breast Cancer Research (9 papers)Disease Markers (8 papers)Cancer Research (7 papers)
Partner nations: United Kingdom United States Australia

In The Last Decade

Diana Eccles

178 papers receiving 8.8k citations

Diana Eccles's Hit Papers

align trajectories log scale

Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results 2008 · 582 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2008 Human Mutation
2006 Nature Genetics
2006 Nature Genetics
2006 Nature Genetics

Peers

Countries citing papers authored by Diana Eccles

Since Specialization

Citations

This map shows the geographic impact of Diana Eccles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Eccles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Eccles more than expected).

Fields of papers citing papers by Diana Eccles

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Diana Eccles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Eccles. The network helps show where Diana Eccles may publish in the future.

Co-authors

The 25 scholars most cited alongside Diana Eccles, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Diana Eccles Line = papers co-authored together Diana Eccles links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 183 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene Nature Genetics ·Nazneen Rahman, Sheila Seal, Deborah J. Thompson, Patrick Kelly, Anthony Renwick, Anna Elliott, Sarah Reid, Katarina Spanova, Rita Barfoot, Tasnim Chagtai, Hiran Jayatilake, Lesley McGuffog, Sandra Hanks, D. Gareth Evans, Diana Eccles, Douglas F. Easton, Michael R. Stratton Hit paper breakdown →	2006	689
2	Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results Human Mutation ·Sharon E. Plon, Diana Eccles, Douglas F. Easton, William D. Foulkes, Maurizio Genuardi, Marc S. Greenblatt, Frans B.L. Hogervorst, Nicoline Hoogerbrugge, Amanda B. Spurdle, Sean V. Tavtigian, (unknown) Hit paper breakdown →	2008	582
3	Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles Nature Genetics ·Sheila Seal, Deborah J. Thompson, Anthony Renwick, Anna Elliott, Patrick Kelly, Rita Barfoot, Tasnim Chagtai, Hiran Jayatilake, Munaza Ahmed, Katarina Spanova, Bernard V. North, Lesley McGuffog, D. Gareth Evans, Diana Eccles, Douglas F. Easton, Michael R. Stratton, Nazneen Rahman Hit paper breakdown →	2006	513
4	ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles Nature Genetics ·Anthony Renwick, Deborah J. Thompson, Sheila Seal, Patrick Kelly, Tasnim Chagtai, Munaza Ahmed, Bernard V. North, Hiran Jayatilake, Rita Barfoot, Katarina Spanova, Lesley McGuffog, D. Gareth Evans, Diana Eccles, Douglas F. Easton, Michael R. Stratton, Nazneen Rahman Hit paper breakdown →	2006	511
5	Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH The Lancet ·Julian R. Sampson, Sunil Dolwani, Siân Jones, Diana Eccles, Anthony Ellis, D. Gareth Evans, Ian M. Frayling, Sheila Jordan, Eamonn R. Maher, Tony Mak, Julie Maynard, Francesca Pigatto, Joan Shaw, Jeremy P. Cheadle	2003	307
6	The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services Breast Cancer Research ·D. Gareth Evans, Julian Barwell, Diana Eccles, Amanda Collins, Louise Izatt, Chris Jacobs, Alan C. Donaldson, Angela F. Brady, Andrew Cuthbert, Rachel Harrison, Sue Thomas, Anthony Howell, (unknown), (unknown), (unknown), (unknown)	2014	226
7	Tumor necrosis factor and its receptors in human ovarian cancer. Potential role in disease progression. Journal of Clinical Investigation ·M. Stuart Naylor, Gordon Stamp, William D. Foulkes, Diana Eccles, Frances R. Balkwill	1993	207
8	Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification British Journal of Cancer ·David J. Bunyan, Diana Eccles, Julie Sillibourne, Esta Wilkins, N. Simon Thomas, J Shea-Simonds, Peter J. Duncan, Claire Curtis, David Robinson, John F. Harvey, Nicholas C.P. Cross	2004	170
9	Loss-of-function mutations in SMARCE1 cause an inherited disorder of multiple spinal meningiomas Nature Genetics ·Miriam J. Smith, James O’Sullivan, Sanjeev S. Bhaskar, Kristen D. Hadfield, Gemma Poke, John Caird, Saba Sharif, Diana Eccles, David Fitzpatrick, Daniel Rawluk, Daniel du Plessis, William G. Newman, D. Gareth Evans	2013	168
10	An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation Breast Cancer Research ·Francisco José Cândido dos Reis, Gordon Wishart, Ed Dicks, David Greenberg, Jem Rashbass, Marjanka K. Schmidt, Alexandra J. van den Broek, Ian O. Ellis, Andrew R. Green, Emad A. Rakha, Tom Maishman, Diana Eccles, Paul D.P. Pharoah	2017	165
11	Psychosocial impact of breast/ovarian (BRCA 1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort British Journal of Cancer ·(unknown), Maggie Watson, Claire Foster, Rosalind A. Eeles, Diana Eccles, Sue Ashley, R Davidson, James Mackay, Patrick J. Morrison, Penelope Hopwood, D. Gareth Evans	2004	162
12	p53 mutation is a common genetic event in ovarian carcinoma. PubMed ·B J Milner, Lindsey Allan, Diana Eccles, HC Kitchener, Renaud Léonard, Kevin F. Kelly, David E. Parkin, N E Haites	1993	153
13	A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Adenomatous Polyposis Cancer Prevention Research ·John Burn, D. Timothy Bishop, Pamela Chapman, Faye Elliott, Lucio Bertario, Malcolm G. Dunlop, Diana Eccles, Anthony E. Ellis, D. Gareth Evans, Riccardo Fodde, Eamonn R. Maher, Gabriela Möslein, Hans F. A. Vasen, Julie Coaker, Robin Phillips, Steffen Bülow, John C. Mathers	2011	151
14	Prospective Observational Study of Breast Cancer Treatment Outcomes for UK Women Aged 18–40 Years at Diagnosis: The POSH Study JNCI Journal of the National Cancer Institute ·Ellen Copson, Bryony Eccles, Tom Maishman, Sue Gerty, Louise Stanton, Ramsey Cutress, Douglas G. Altman, Lorraine Durcan, Peter Simmonds, Gill Lawrence, J. Louise Jones, Judith M. Bliss, Diana Eccles	2013	141
15	Hereditary desmoid disease due to a frameshift mutation at codon 1924 of the APC gene. PubMed ·Diana Eccles, Rob B. van der Luijt, Cor Breukel, H. Bullman, David J. Bunyan, Azetta Fisher, John Barber, Clotilde Boulay, John Primrose, John Burn, Riccardo Fodde	1996	138
16	Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics Journal of Medical Genetics ·Antonis C. Antoniou, Rachel Hardy, Lyndon Walker, D. Gareth Evans, A Shenton, Rosalind A. Eeles, Susan Shanley, Gabriella Pichert, Louise Izatt, Stephen Rose, Gillian Douglas, Diana Eccles, Patrick J. Morrison, Jessica L. Scott, Ron Zimmern, Douglas F. Easton, Paul D.P. Pharoah	2008	137
17	Pregnancies, Breast-Feeding, and Breast Cancer Risk in the International BRCA1/2 Carrier Cohort Study (IBCCS) JNCI Journal of the National Cancer Institute ·Nadine Andrieu, David E. Goldgar, Douglas F. Easton, Matti A. Rookus, Richard M. Brohet, Antonis C. Antoniou, Susan Peock, D. Gareth Evans, Diana Eccles, Fiona Douglas, Catherine Noguès, Marion Gauthier‐Villars, Agnès Chompret, Flora E. van Leeuwen, Irma Kluijt, Javier Benı́tez, Brita Arver, Edith Oláh, Jenny Chang‐Claude	2006	136
18	Screening for Familial Ovarian Cancer: Failure of Current Protocols to Detect Ovarian Cancer at an Early Stage According to the International Federation of Gynecology and Obstetrics System Journal of Clinical Oncology ·D. Stirling, D. Gareth Evans, Gabriella Pichert, A Shenton, Elaine N. Kirk, S. Rimmer, C. M. Steel, Sheila Lawson, RMC Busby-Earle, Jane Walker, Fiona Lalloo, Diana Eccles, Anneke Lucassen, Mary Porteous	2005	117
19	Prediction of single‐nucleotide substitutions that result in exon skipping: identification of a splicing silencer inBRCA1exon 6 Human Mutation ·Michela Raponi, Jana Královičová, Ellen Copson, Petr Divina, Diana Eccles, Peter Johnson, Diana Baralle, Igor Vořechovský	2011	106
20	Variants in CHEK2 Other than 1100delC Do Not Make a Major Contribution to Breast Cancer Susceptibility The American Journal of Human Genetics ·Mieke Schutte, Sheila Seal, Rita Barfoot, Hanne Meijers‐Heijboer, Marijke Wasielewski, D. Gareth Evans, Diana Eccles, Carel Meijers, Frans P. Lohman, Jan G.M. Klijn, Ans van den Ouweland, P. Andrew Futreal, Katherine L. Nathanson, Barbara L. Weber, Douglas F. Easton, Michael R. Stratton, Nazneen Rahman	2003	97

About Diana Eccles

Diana Eccles is a scholar working on Genetics, Oncology, Molecular Biology, Cancer Research and Pathology and Forensic Medicine, having authored 183 papers that have together received 9.0k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (97 papers), Genetic factors in colorectal cancer (44 papers), Cancer Genomics and Diagnostics (31 papers), DNA Repair Mechanisms (21 papers), Global Cancer Incidence and Screening (16 papers), Breast Cancer Treatment Studies (16 papers), Cancer-related Molecular Pathways (14 papers) and Genomic variations and chromosomal abnormalities (14 papers). The work is most often cited by research in Cancer Research (2.6k citations), Genetics (4.6k citations), Pathology and Forensic Medicine (2.2k citations), Oncology (2.9k citations) and Reproductive Medicine (654 citations). Diana Eccles has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include D. Gareth Evans, Douglas F. Easton, Nazneen Rahman, Sheila Seal, Michael R. Stratton, Rita Barfoot, Anthony Renwick, Hiran Jayatilake, Lesley McGuffog and Ian Campbell. Their work appears in journals such as Journal of Medical Genetics, British Journal of Cancer, Breast Cancer Research, Disease Markers and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Diana Eccles

Impact in

Papers in i

In The Last Decade

Diana Eccles

Diana Eccles's Hit Papers

Peers

Countries citing papers authored by Diana Eccles

Fields of papers citing papers by Diana Eccles

All Works

About Diana Eccles

Explore authors with similar magnitude of impact

Papers in